These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 29203480

  • 1. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design.
    Lepak AJ, Zhao M, VanScoy B, Ambrose PG, Andes DR.
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203480
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model.
    Lepak AJ, Zhao M, Andes DR.
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181375
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model.
    Lepak AJ, Marchillo K, Andes DR.
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1265-72. PubMed ID: 25512406
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties.
    James KD, Laudeman CP, Malkar NB, Krishnan R, Polowy K.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919891
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.
    Andes D, Diekema DJ, Pfaller MA, Bohrmuller J, Marchillo K, Lepak A.
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2497-506. PubMed ID: 20385855
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model.
    Lepak AJ, Marchillo K, VanHecker J, Diekema D, Andes DR.
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5642-8. PubMed ID: 24002092
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA, Locke JB, James KD, Bartizal K, Sobel JD.
    J Antimicrob Chemother; 2017 May 01; 72(5):1355-1358. PubMed ID: 28158577
    [Abstract] [Full Text] [Related]

  • 14. Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species.
    Locke JB, Almaguer AL, Zuill DE, Bartizal K.
    Antimicrob Agents Chemother; 2016 Oct 01; 60(10):6100-7. PubMed ID: 27480852
    [Abstract] [Full Text] [Related]

  • 15. In vitro potency and fungicidal activity of CD101, a novel echinocandin, against recent clinical isolates of Candida spp.
    Hall D, Bonifas R, Stapert L, Thwaites M, Shinabarger DL, Pillar CM.
    Diagn Microbiol Infect Dis; 2017 Nov 01; 89(3):205-211. PubMed ID: 28826987
    [Abstract] [Full Text] [Related]

  • 16. Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.
    Bader JC, Lakota EA, Flanagan S, Ong V, Sandison T, Rubino CM, Bhavnani SM, Ambrose PG.
    Antimicrob Agents Chemother; 2018 Jun 01; 62(6):. PubMed ID: 29555634
    [Abstract] [Full Text] [Related]

  • 17. Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.
    Lepak A, Castanheira M, Diekema D, Pfaller M, Andes D.
    Antimicrob Agents Chemother; 2012 Nov 01; 56(11):5875-82. PubMed ID: 22948870
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.
    Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.
    Int J Antimicrob Agents; 2017 Sep 01; 50(3):352-358. PubMed ID: 28689871
    [Abstract] [Full Text] [Related]

  • 20. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A, Ferriols-Lisart R, Aguilar G, Ezquer-Garín C, Belda FJ, Guglieri-López B.
    Int J Antimicrob Agents; 2018 Jan 01; 51(1):115-121. PubMed ID: 28666752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.